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Background: Although cardiac autonomic neuropathy is one of major complications of diabetes mellitus (DM),
anatomical data on cardiac innervation of diabetic animal models is scant and controversial. We performed this
study to check whether long-term diabetic state impacts the anatomy of intracardiac ganglia in Goto-Kakizaki (GK)
rats, a genetic model of type 2 DM.
Methods: Twelve GK rats (276 ± 17 days of age; mean ± standard error) and 13 metabolically healthy Wistar rats
(262 ± 5 days of age) as controls were used for this study. Blood glucose was determined using test strips, plasma
insulin by radioimmunoassay. Intrinsic ganglia and nerves were visualized by acetylcholinesterase histochemistry on
whole hearts. Ganglion area was measured, and the neuronal number was assessed according to ganglion area.
Results: The GK rats had significantly elevated blood glucose level compared to controls (11.0 ± 0.6 vs. 5.9 ±
0.1 mmol/l, p < 0.001), but concentration of plasma insulin did not differ significantly between the two groups
(84.0 ± 9.8 vs. 67.4 ± 10.9 pmol/l, p = 0.17). The GK rats contained significantly fewer intracardiac ganglia, decreased
total area of intracardiac ganglia (1.4 ± 0.1 vs. 2.2 ± 0.1 mm2, p < 0.001) and smaller somata of ganglionic neurons.
Mean total number of intracardiac neurons in GK rats was 1461 ± 62, while this number in control rats was higher
by 39% and reached 2395 ± 110 (p < 0.001).
Conclusions: Results of our study demonstrate the decreased number of intracardiac neurons in GK rats compared
to metabolically healthy Wistar rats of similar age. It is likely that the observed structural remodelling of intracardiac
ganglia in GK rats is caused by a long-term diabetic state.
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Long-term diabetes mellitus (DM) impacts the ultra-
structure, cytochemistry and function of neurons and
nerves, and leads to a variety of neuropathies [1-4]. De-
cline in the number of peripheral and central neurons
[5-7], decrease of the density of nerve fibres [8],
disorganization of the axonal terminals and myelinated
nerve fibres [9,10] have been reported in diabetic pa-
tients and in animal models of DM. The degenerative ef-
fect of DM on neurons and nerves is explained by
microvascular insufficiency and biochemical mecha-
nisms [11]. It has been shown that both ultrastructural
abnormalities and loss of capillaries result in impaired
blood flow of autonomic ganglia and central neurons in* Correspondence: batuda@med.kmu.lt
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distribution, and reproduction in any mediumDM [12,13]. Additionally, the metabolism of glucose re-
sults in the excessive accumulation of free radicals that
has a direct neurotoxic effect in DM [14].
One of the major complications of DM is cardiac auto-
nomic neuropathy that damages heart innervation [15].
Clinical studies suggest that cardiac autonomic neur-
opathy in DM impairs the baroreflex control of heart rate
and cardiac tolerance for exercise as well as increases the
risk for arrhythmias, silent myocardial ischemia or heart
stroke [11]. Although the mechanisms of cardiac auto-
nomic neuropathy in DM are poorly understood, func-
tional studies imply the role of intracardiac ganglia in
development of baroreflex circuitry defects and arrhyth-
mias [16,17]. However, anatomical data on the intracardiac
ganglia in DM is still scant and controversial. Degenerative
ultrastructural changes of the nerve fibres have been dem-
onstrated within atria of diabetic patients [1] and animal
models [9]. It was shown that DM significantly decreasesntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[17]. On the contrary, other authors found unchanged
abundance of cholinergic neurons and even increased
density of the cholinergic nerve fibres in the region of si-
noatrial node of diabetic mice [18].
Experimental studies have been focused mainly on animal
models of type 1 DM [16-18]. One of genetic models of
type 2 DM is the Goto-Kakizaki (GK) rat. This model was
generated by selective inbreeding of non-diabetic Wistar
rats with impaired glucose tolerance over numerous gener-
ations [19]. The GK rats develop mild hyperglycemia,
glucose intolerance, impaired glucose-induced insulin
secretion and other characteristic disorders of type 2 DM
early in life [20]. In spite of only mild hyperglycemia in GK
rats, both functional and morphological manifestation of
diabetic neuropathy have been demonstrated [21]. Goto-
Kakizaki rats have been used extensively to study the effects
of DM on cardiovascular, renal and endocrine function as
well as possible prevention of diabetic neuropathy [20-28].
Up to date there is a lack of anatomical study on the intra-
cardiac ganglia of GK rats, as we did not find any morpho-
logical data on the intracardiac ganglia of the type 2
diabetic animal models.
The goal of our study therefore was to check whether
the long-term diabetic state impacts the anatomy of intra-
cardiac ganglia in GK rats. We hypothesised that the long-
term diabetic state would affect the quantity and size of
intracardiac ganglia as well as total number of intracardiac
neurons in GK rats.
Methods
Animals
All experiments in this study conformed to animal welfare
regulations of both German and Lithuanian states and were
approved by local committees for animal care and use
following the Guide for the Care and Use of Laboratory
Animals (NIH Publication No. 85–23, revised 1985).
Twelve male diabetic GK rats (inbred, Taconic M&B, Ry,
Denmark) were used. Thirteen male Wistar rats (outbred,
Schönwalde, Germany) were used as controls. Age of GK
rats was 276 ± 17 days (mean ± standard error). Age of
control rats was 262 ± 5 days, and it did not differ signifi-
cantly from GK rats. Rats were fed a standard diet
(Altromin 1324, Altromin, Lage, Germany) ad libitum. At
the moment of sacrifice GK rats weighed 433 ± 5 g, while
control rats 512 ± 10 g.
Blood and tissue sampling
All procedures of blood and tissue sampling were
performed on rats that were deeply anesthetised using
vaporized isoflurane. Isoflurane (Merck, Darmstadt,
Germany) was vaporized at the bottom of a closed glass
tank. The rats inhaled the isoflurane and air mixture in the
glass tank until being deeply anesthetised. Afterwards, therats underwent a median laparotomy and thoracotomy. To
prevent the formation of blood clots inside the heart, 1000
units of heparin (Liquemin, Roche, Grenzach-Whylen,
Germany) were injected into the caudal vein, i.e. equivalent
of inferior vena cava in humans. The blood samples were
then drawn after puncture of the caudal vein. The caudal
vein was cut immediately and the rats were sacrificed by ex-
sanguination still being under deep anesthesia by isoflurane.
The hearts with lungs were removed en block and rinsed in
phosphate buffered saline (PBS) at 4°C. The composition of
PBS (pH 7.4) was (in mmol/l): NaCl, 111; Na2HPO4, 8.1;
NaH2PO4, 1.86. The hearts were then cryo-preserved for
2 hours at 4°C PBS containing 20% sucrose and frozen in
the same PBS-sucrose at −20°C. The hearts were stored on
dry ice during shipping to Lithuanian University of Health
Sciences for further investigation.
Intact heart preparations
The frozen hearts were thawed by placing them in PBS at
4°C and perfused by injection of PBS. To improve
visualization of the neural structures, the atrial walls were
distended by injection of warm 20% gelatin solution in PBS.
The pericardium, lungs, pulmonary arteries and mediastinal
fat were removed from the pressure-inflated hearts. The
prepared hearts were pre-fixed for 15 minutes in 4% para-
formaldehyde solution in PBS at 4°C (pH 7.4). Following
pre-fixing the hearts were rinsed for 30 minutes at 4°C in
the PBS containing hyaluronidase (0.5 mg/100 ml, Serva,
Heidelberg, Germany) and tetraisopropylphosphoramide
(Iso-OMPA, 0.5 mmol/l, Sigma, St. Louis, USA), which in-
hibits pseudocholinesterase.
The nerves and ganglia were stained by the acetyl-
cholinesterase (AChE) histochemistry as described in
detail previously [29,30]. The hearts were incubated
for 2 hours at 4°C in the AChE staining medium
(pH 5.6). The composition of AChE staining medium
was (in mmol/l): Na acetate, 60; acetylthiocholine-
iodide (Serva, Heidelberg, Germany), 2; Na citrate, 15;
CuSO4, 3; K3Fe(CN)6, 0.5. The staining medium was
supplemented by Triton-X 100 (Sigma, St. Louis, USA)
up to 1% and hyaluronidase (0.5 mg/100 ml, Serva,
Heidelberg, Germany). Since the fat on the heart base
hindered the staining medium from accessing the neural
structures, additional dissection of the fat was performed
during staining. Following staining, intact hearts were
fixed overnight in 4% paraformaldehyde in PBS (pH 7.4).
Heart preparations were examined in distilled water
using a stereomicroscope Stemi 2000C (Zeiss, Göttingen,
Germany; Figure 1) and preserved in the above para-
formaldehyde.
Analysis of blood glucose and plasma insulin levels
Concentration of blood glucose was analysed with
MediSense Precision Xtra glucometer and MediSense
Figure 1 Intact heart preparations. Dorsal view of the heart from GK (a) and control (b) rats demonstrates the intracardiac ganglia (arrows)
and intracardiac nerves stained for acetylcholinesterase. Dotted lines demarcate the cardiac region that was used for quantitative analysis of the
nerve density. Boxed areas in a and b are enlarged in panels c and d, respectively. Note that intracardiac ganglia in GK rat (c) are sparse
compared to the control rat (d). Several intracardiac ganglia (arrows) from GK (e) and control (f) rats are shown at high magnification with ganglion
areas and neuronal numbers indicated nearby ganglia. Neuronal numbers are assessed by linear regression plots as shown in Figure 3a, b. CV, caudal vein;
LCV, left cranial vein; LPV, left pulmonary vein; MPV, middle pulmonary vein. Bars 4 mm (a, b), 1 mm (c, d), 0.4 mm (e, f).
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Germany). Concentration of plasma insulin was analysed
by radioimmunoassay using Coat-A-Count kits (DPC,
Biermann GmbH, Bad Nauheim, Germany).Analysis of total number and area of intracardiac ganglia
The intracardiac ganglia were counted and photographed
on AChE-stained intact hearts at 50× magnification of a
stereomicroscope Stemi 2000C equipped with an MRC5
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Germany). The measurements of ganglion area were done
manually by marking the contours of the photographed
ganglia with outline spline method of the Axiovision 4.7.2
software. For counting the intracardiac ganglia we
subdivided the surface of rat heart into regions of the heart
hilum and dorsal left atrial region, as these two areas con-
tain the vast majority of intracardiac ganglia in rat [29].
Analysis of total number and size of intracardiac neurons
To estimate the neuronal number of intracardiac ganglia
and the size of neuronal somata, 50 AChE-stained gan-
glia from each group of controls and GK rats were
excised and covered using water soluble medium
Aquatex (Merck, Darmstadt, Germany). The neuronal
somata inside these ganglia were counted at 400× magnifi-
cation using an AxioImager Z1 light microscope (Zeiss,
Göttingen, Germany). Based on the ganglion area and the
number of ganglionic neurons the linear regression formu-
las both for controls and GK rats were calculated by SPSS
16.0 software (SPSS Inc., Chicago, USA). The obtained lin-
ear regression formulas were then used to assess theFigure 2 Blood glucose and plasma insulin levels as well as number a
significantly elevated blood glucose levels compared to controls (a), while
groups (b). Both the number of intracardiac ganglia (c) and the total area o
controls.**p < 0.01, ***p < 0.001.neuronal number inside each ganglion (Figure 1e, f). Mea-
surements of the neuronal soma area were performed on
100 neurons selected randomly from each group of con-
trols and GK rats by the same AxioImager Z1 microscope
and Axiovision software.
Analysis of density of epicardial nerves
The stereomicroscopically visible epicardial nerves that
supply rat ventricles via the dorsal wall of the left atrium
and sinus of the left cranial vein were photographed
using a stereomicroscope Stemi 2000C, Axiocam MRC5
camera and Axiovision 4.7.2 software (Zeiss, Jena,
Göttingen, Germany). The AChE-stained nerves were
outlined on the computer screen, and the percentage of
outlined pixels in the digital image was estimated by the
histogram method of Photoshop 7.0 software (Adobe
Systems, USA).
Statistical analysis
Results are presented as mean ± standard error. Statis-
tical comparisons between GK and control groups were
performed using Mann–Whitney U two-tailed test (SPSSnd total area of intracardiac ganglia. Goto-Kakizaki rats exhibit
the plasma insulin level is not significantly different between two
f ganglia (d) are significantly decreased in GK rats compared to
Table 1 Number and total area (in mm2) of intracardiac
ganglia stained for acetylcholinesterase (mean ± standard
error) in GK (n = 12) and control (n = 13) rats
Cardiac region GK rats Controls
Number of ganglia
Heart hilum 39 ± 4 56 ± 5*
Dorsal atrial region 17 ± 1 21 ± 2
Overall 55 ± 4 78 ± 6**
Total area of ganglia
Heart hilum 0.79 ± 0.05 1.45 ± 0.10***
Dorsal atrial region 0.59 ± 0.04 0.79 ± 0.05**
Overall 1.38 ± 0.06 2.22 ± 0.10***
*p < 0.05, **p < 0.01, ***p < 0.001.
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cepted at p < 0.05.
Results
Blood glucose and plasma insulin levels
Blood glucose level in control rats was 5.9 ± 0.1 mmol/l.
It was significantly increased to 11.0 ± 0.6 mmol/l in GKFigure 3 Assessment of the total number of intracardiac neurons. Cor
for the heart of GK (a) and control (b) rats. Note the strong correlation bet
Total neuronal number per heart (c) and neuronal numbers in both the he
GK rats compared to controls. **p < 0.01, ***p < 0.001; R, correlation coeffici
inside ganglion.rats (p < 0.001; Figure 2a). Plasma insulin level in control
rats was 67.4 ± 10.9 pmol/l, but it did not differ signifi-
cantly from plasma insulin level 84.0 ± 9.8 pmol/l of GK
rats (p = 0.17; Figure 2b).
Total number and area of intracardiac ganglia
Control rats contained 78 ± 6 intracardiac ganglia while
this number was reduced to 55 ± 4 in GK rats (p < 0.01;
Figure 2c). Significant loss of intracardiac ganglia and
considerably reduced total area of intracardiac ganglia
were found in the heart hilum (Table 1). Loss of intra-
cardiac ganglia in the dorsal atrial region was not signifi-
cant (p = 0.06), but total area of intracardiac ganglia in
this region was significantly reduced as well (Table 1).
Total areas of intracardiac ganglia in GK rats and con-
trols were 1.38 ± 0.06 mm2 and 2.22 ± 0.10 mm2, re-
spectively (p < 0.001; Figure 2d).
Total number and size of intracardiac neurons
Strong correlation between the ganglion area and neur-
onal number was found both for GK rats and controls
(Figure 3a, b). Linear regression revealed that therelation between the ganglion area and neuronal number is shown
ween the ganglion area and the neuronal number in both groups.
art hilum and the dorsal atrial region (d) are significantly decreased in
ent. x, ganglion area in mm2; y, number of ganglionic neurons
Figure 4 Total number of intracardiac neurons plotted against
age (in days) of GK (n = 12) and control (n = 13) rats. Note that
the decrease in total neuronal number in GK rats is not gradual in
the investigated age range.
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rats and controls may be correspondingly approximated
by linear equation formulas N = 1063 × S and N =
1071 × S, where N is neuronal number and S is ganglion
area in square millimetres (Figure 3a, b).Figure 5 Density of epicardial nerves. Drawings of epicardial nerves in t
and four control rats (a) demonstrate the similar density of nerves between
percentage of area covered by the nerves) in the dorsal left atrial region (bTotal number of intracardiac neurons in GK rats was
significantly decreased in respect to control animals
(1461 ± 62 vs. 2395 ± 110, p < 0.001; Figure 3c). Heart
hilum of GK rats and controls accumulated 836 ± 52 and
1544 ± 103 neurons, respectively (p < 0.001; Figure 3d).
The dorsal atrial region of GK rats and controls accu-
mulated 625 ± 37 and 851 ± 52 neurons, respectively
(p < 0.01; Figure 3d). The decrease of the total number
of intracardiac neurons was not gradual in the investi-
gated age range of GK rats (Figure 4). In addition, the
area of neuronal soma in GK rats was significantly de-
creased compared with control rats (810 ± 19 μm2 vs.
934 ± 23 μm2, p < 0.001).Density of epicardial nerves
Density of epicardial nerves in GK rats was 8.7 ± 0.6%
while in controls it was 9.5 ± 0.6% (Figure 5). The dens-
ity did not differ significantly between the two groups
(p = 0.23; Figure 5). Although quantitative analysis of
density of nerves was limited to the epicardium of the
dorsal wall of the left atrium, density of nerves in other
epicardial regions was evidently similar between GK rats
and controls.he dorsal left atrial region stained for acetylcholinesterase from four GK
GK rats and controls. Density of epicardial nerves (expressed as
) does not differ significantly between GK rats and controls.
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The results of our study demonstrate that adult GK rats
aged approximately nine months exhibit marked hyper-
glycemia, but no significant hyperinsulinemia. Hearts of
GK rats contain fewer ganglia than control Wistar rats
of similar age, and the area of intracardiac ganglia is sig-
nificantly decreased in GK rats. Total number of intra-
cardiac neurons in GK rats is about 39% less than in
controls. Moreover, the size of soma of intracardiac neu-
rons is decreased by 13% in GK rats. Hence, we consider
that significant structural remodelling of the intracardiac
ganglia is characteristic for adult GK rats. This remodel-
ling of the intracardiac ganglia in GK rats is likely to be
due to metabolic disorders associated with the long-
term type 2 DM. Our study is a first demonstration of
the structure of intracardiac ganglia in type 2 diabetic
rats.
Although the functional impairment of cardiac auto-
nomic innervation in DM has been extensively studied
[31-37], there is still very little data on anatomy of intra-
cardiac ganglia of diabetic animal models. Reduction of
size of both intracardiac ganglia and intracardiac neu-
rons has been reported in type 1 diabetic mice [16,18].
Our study demonstrates that decrease of the total num-
ber of intracardiac neurons as well as reduction of size
of both intracardiac ganglia and intracardiac neurons is
characteristic for adult type 2 diabetic rats. Finding of
the decreased number of intracardiac neurons in GK
rats is new, because no other studies have attempted to
estimate the total number of intracardiac neurons in this
animal model of DM. Previous study by Mabe and Hoover
[18] on type 1 diabetic mice reported no difference in
abundance of intracardiac neurons after 4 months of
DM [18]. Although the exact cause of different findings
between our study and the report by Mabe and Hoover
[18] is unknown, this disparity might be explained by
1) different kind of DM and longer exposure of animals to
DM in our study, 2) different animal model used, and
3) different methodological approach to quantify the intra-
cardiac nerve cells between the studies. We attempted
to quantify the vast majority of rat intracardiac ganglia,
because they were readily visible on the surface of intact
heart preparations. In contrast, Mabe and Hoover [18]
counted neurons in serial cryostat sections of mouse
atria. It seems that cryostat sectioning of very thin atria
of mouse may provide significant underestimation of the
total number of intracardiac neurons. Indeed, the esti-
mate of total neuronal number of intracardiac neurons
in control mice reported by Mabe and Hoover [18] is
more than five times less compared to that reported by
other authors who counted intracardiac neurons in whole-
mount preparations of mouse atria [38].
Loss of neurons has been previously reported in retina
[7], intestines [39-41] and stomach [42] of type 1 diabeticrats as well as in retina [43,44] and hippocampus [6] of
type 1 diabetic mice. The extent of neuronal loss in GK
rats identified in our study is comparable to that reported
in intestines and stomach of type 1 diabetic rats [39-42],
and even higher compared to retina of diabetic mice
[43,44]. However, the molecular mechanism by which the
nerve cells develop structural abnormalities and neuronal
number decreases is not yet clear. Generally, it is assumed
that oxidative stress, exposure to advanced glycation end
products, depletion of neurotrophic factors or activation
of polyol pathway might contribute to the neuronal death
[43,44]. Activation of the polyol pathway has been shown
to account for the induction of early neuronal apoptosis of
retinal ganglion cells [12]. Thus, it would be tempting to
look for apoptosis of intracardiac neurons of GK rats
in future.
We found similar density of major nerves in the left
atrial epicardium between GK rats and controls. Previous
studies have found reduced [45-47], unchanged [33] or in-
creased [18] density of intracardiac nerves in diabetic ani-
mal models. This diversity of findings regarding density of
intracardiac nerves may be attributed to the differences in
the functional kind of nerves and cardiac region analysed
by previous studies. It is generally accepted that long-term
DM results in loss of peptidergic sensory nerve fibres
[45,46]. However, it is also supposed that DM does not
affect the density of adrenergic intracardiac nerves signifi-
cantly [17,18,33]. Decrease of ventricular but not atrial in-
nervation density by neuropeptide Y-positive nerves was
observed in rats after long-term DM [47]. Density of cho-
linergic nerves has been found as significantly decreased
[17] or increased [18] in right atrium of diabetic animal
models. Taken together with the above findings by other
authors, our study demonstrates that the major nerves in
the left atrial epicardium of adult rat remain intact after
long-term type 2 DM. These major nerves in the left atrial
epicardium presumably include both adrenergic and cho-
linergic nerve fibres with the high proportion of the fibres
of adrenergic kind [38]. Since AChE histochemistry stains
both cholinergic and adrenergic nerves [48], our technique
did not allow us to discriminate between those two kinds
of fibres. Therefore, staining of both cholinergic and ad-
renergic nerves in different cardiac regions analysed could
explain the differences of findings between our study and
other authors [17,18]. Future immunohistochemical stud-
ies for cholinergic, adrenergic and peptidergic markers
should ascertain the effect of type 2 DM on regional distri-
bution of intracardiac nerve fibres in GK rats.
With respect to significance of the decreased number
of intracardiac neurons in DM, our findings support the
idea that intracardiac ganglia might be involved in para-
sympathetic dysfunction observed in diabetic patients
[11] and animal models [16,49]. Since the intracardiac
ganglia represent an efferent limb of baroreflex circuitry,
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pair the parasympathetic efferent control of cardiac tis-
sues and could result in the diabetes-induced baroreflex
deficit [16]. Additionally, the decreased number of intra-
cardiac neurons may result in the defects of balance be-
tween parasympathetic and sympathetic tone on the
heart. Autonomic imbalance characterized by the im-
pairment of parasympathetic function and a relative in-
crease of sympathetic function is one of serious
complications that appear early in DM [35,50]. Thus,
further studies are essential to find measures preventing
negative effect of DM on intracardiac ganglia.
The following limitations of our study should be consid-
ered: 1) We did not perform functional studies to test if
the parasympathetic function of intracardiac ganglia and
intracardiac nerves is preserved in GK rats; 2) We did not
perform electron microscopic analysis of intracardiac gan-
glia and immunohistochemical characterization of adren-
ergic, cholinergic and peptidergic nerve fibres; 3) We did
not estimate the total number of intracardiac neurons in
newborn and juvenile GK rats to determine the timing of
onset of the neuronal loss.
Conclusions
We conclude that GK rats with the age of about nine
months exhibit shrinkage of intracardiac ganglia and a
decrease in the total number of intracardiac neurons.
Whether and how this structural remodelling of intra-
cardiac ganglia results in functional deficits of cardiac
innervation in GK rats remains to be elucidated.
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